These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16634685

  • 1. Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1.
    Debnath AK.
    Expert Opin Investig Drugs; 2006 May; 15(5):465-78. PubMed ID: 16634685
    [Abstract] [Full Text] [Related]

  • 2. HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds.
    Liu S, Wu S, Jiang S.
    Curr Pharm Des; 2007 May; 13(2):143-62. PubMed ID: 17269924
    [Abstract] [Full Text] [Related]

  • 3. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S, Zhao Q, Debnath AK.
    Curr Pharm Des; 2002 May; 8(8):563-80. PubMed ID: 11945159
    [Abstract] [Full Text] [Related]

  • 4. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
    Zheng B, Wang K, Lu L, Yu F, Cheng M, Jiang S, Liu K, Cai L.
    AIDS; 2014 Jun 01; 28(9):1251-60. PubMed ID: 24625369
    [Abstract] [Full Text] [Related]

  • 5. ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
    Yu F, Lu L, Liu Q, Yu X, Wang L, He E, Zou P, Du L, Sanders RW, Liu S, Jiang S.
    Biochim Biophys Acta; 2014 May 01; 1838(5):1296-305. PubMed ID: 24388952
    [Abstract] [Full Text] [Related]

  • 6. HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides.
    Liu S, Jing W, Cheung B, Lu H, Sun J, Yan X, Niu J, Farmar J, Wu S, Jiang S.
    J Biol Chem; 2007 Mar 30; 282(13):9612-9620. PubMed ID: 17276993
    [Abstract] [Full Text] [Related]

  • 7. Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.
    Liu S, Lu H, Niu J, Xu Y, Wu S, Jiang S.
    J Biol Chem; 2005 Mar 25; 280(12):11259-73. PubMed ID: 15640162
    [Abstract] [Full Text] [Related]

  • 8. High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques.
    Liu S, Jiang S.
    Curr Pharm Des; 2004 Mar 25; 10(15):1827-43. PubMed ID: 15180543
    [Abstract] [Full Text] [Related]

  • 9. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.
    J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27795416
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins.
    Jurado S, Cano-Muñoz M, Morel B, Standoli S, Santarossa E, Moog C, Schmidt S, Laumond G, Cámara-Artigas A, Conejero-Lara F.
    J Mol Biol; 2019 Aug 09; 431(17):3091-3106. PubMed ID: 31255705
    [Abstract] [Full Text] [Related]

  • 12. Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitors.
    He Y, Cheng J, Li J, Qi Z, Lu H, Dong M, Jiang S, Dai Q.
    J Virol; 2008 Jul 09; 82(13):6349-58. PubMed ID: 18417584
    [Abstract] [Full Text] [Related]

  • 13. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.
    Shu W, Liu J, Ji H, Radigen L, Jiang S, Lu M.
    Biochemistry; 2000 Feb 22; 39(7):1634-42. PubMed ID: 10677212
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The M-T hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance.
    Chong H, Yao X, Qiu Z, Sun J, Qiao Y, Zhang M, Wang M, Cui S, He Y.
    J Antimicrob Chemother; 2014 Oct 22; 69(10):2759-69. PubMed ID: 24908047
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.